ASH 2018 – presentations and articles
During the American Hematology Meeting (ASH), Oncopeptides presented data from two ongoing studies, ANCHOR and HORIZON. These presentations as well as publications in the media are presented below. The...
Presentations
Jakob Lindberg, CEO, Oncopeptides – Company presentation post ASH
Jakob Lindberg, CEO, Oncopeptides - Company presentation post ASH 2018
Professor Paul G. Richardson presentation at ASH 2018 – The HORIZON study
Professor Paul G. Richardson presentation at ASH 2018 – The HORIZON study
60th ASH Annual Meeting & Exposition – Poster ANCHOR
ANCHOR poster. Oncopeptides presents the first interim data with melflufen (Ygalo®) from the ongoing phase I/II study ANCHOR at the 60th ASH meeting in San Diego, California, USA (December 1, 2018).
Jefferies 2018 London Healthcare conference – Presentation & webcast
Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies 2018 Healthcare conference in London November 14. The presentation was also recorded. Click on the recording (mp3-file) to view...
ASH Abstracs 2018
Oncopeptides to present updated data from the two ongoing trials ANCHOR and HORIZON in patients with RRMM at ASH in December 2018. The abstract data cut for ANCHOR was July 18th and for HORIZON, May 10th....
Lunch presentation at DNB
Corporate presentation by Jakob Lindberg, CEO, Oncopeptides AB, at DNB 25 September 2018.
Presentation at 23rd Congress of The European Hematology Association (EHA)
The updated phase II-data show a clinical data set with an Overall Response Rate (ORR) of 32.1% and a Clinical Benefit Rate (CBR) of 39.3% with Ygalo® in relapsed/refractory multiple myeloma patients ...
Jefferies Health Care conference, New York – Presentation
Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies Healthcare Conference in New York June 7.
Jakob Lindberg, CEO, is interviewed in Di tv
Oncopeptides CEO Jakob Lindberg interviewed at DI Börsmorgon (Di tv) about the Q1 Interim report and the future, May 17, 2018.
Carnegie Healthcare Seminar 2018 – presentation
Oncopeptides CEO Jakob Lindberg held a presentation at Carnegie Healthcare Seminar on March 14.
SCF Life Science Seminarium – presentation
Oncopeptides CEO Jakob Lindberg held a presentation at Stockholm Corporate Finance Live Science Seminarium March 7. Click here to view the recorded presentation.
ABGSC Orphan Drug Day 2018 – Presentation
Oncopeptides presentation at the ABG Office in Stockholm, Sweden
DNB Nordic Healthcare Conference 2017 – Oslo
Oncopeptides' presentation at DNB in Oslo, 14 December
ASH summary Webcast
Oncopeptides had a press conference on December 13. The conference was recorded. Click here to view the Webcast.
59th ASH Annual Meeting & Exposition – Posters
Horizon Poster (9 Dec 2017) and O-12-M1 Poster (10 Dec 2017)
Carnegie Healthcare Day in New York – presentation
Oncopeptides presentation at Carnegie, New York, 5 December 2017.